MedPath

Microbial Colonization of Oral Probiotics

Not Applicable
Conditions
Microbial Colonization
Interventions
Dietary Supplement: Probiotic S. salivarius K12 lozenges containing prebiotic B
Dietary Supplement: Probiotic S. salivarius K12 powder containing prebiotic B
Dietary Supplement: Probiotic S. salivarius K12 powder containing prebiotics A and B
Dietary Supplement: Streptococcus salivarius K12 lozenge
Dietary Supplement: Probiotic S. salivarius K12 powder
Dietary Supplement: Probiotic S. salivarius M18 lozenges
Dietary Supplement: Probiotic S. salivarius K12 powder containing prebiotic A
Dietary Supplement: Probiotic S. salivarius K12 lozenges containing prebiotic A
Dietary Supplement: Probiotic S. salivarius K12 lozenges containing prebiotics A and B
Dietary Supplement: Probiotic S. salivarius M18 lozenges containing prebiotic B
Dietary Supplement: Probiotic S. salivarius M18 + lozenges containing prebiotic A and B
Dietary Supplement: Probiotic S. salivarius M18 lozenges containing prebiotic A
Registration Number
NCT05375383
Lead Sponsor
BLIS Technologies Limited
Brief Summary

The aim of this study is to evaluate the colonization efficacy of probiotic lozenges and powders containing specific prebiotics in healthy adults

Detailed Description

This is a double-blind, randomized controlled colonization pilot study with no cross over to evaluate the colonization efficacy of lozenges and powders containing two different commercially available probiotic bacteria (S. salivarius K12 ) or S. salivarius M18 with or without 2 different prebiotic sugars or their combinations.

Participants will be randomly assigned to one of the 12 groups consuming probiotic lozenge or powder containing Streptococcus salivarius K12 or S. salivarius M18 with or without prebiotics (e.g. sugars that may promote probiotic activity) over a seven day period. Saliva samples will be collected at predetermined time points pre and post intervention. Colonisation efficacy will be determined by enumerating the probiotic in the saliva samples using standard microbiological techniques.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Probiotic S. salivarius K12 lozenges containing prebiotic BProbiotic S. salivarius K12 lozenges containing prebiotic BStreptococcus salivarius K12 lozenge with prebiotic
Probiotic S. salivarius K12 powder containing prebiotic BProbiotic S. salivarius K12 powder containing prebiotic BStreptococcus salivarius K12 powder with prebiotic
Probiotic S. salivarius K12 powder containing prebiotic A and BProbiotic S. salivarius K12 powder containing prebiotics A and BStreptococcus salivarius K12 powder with prebiotic
Streptococcus salivarius K12 lozengeStreptococcus salivarius K12 lozengeStreptococcus salivarius K12 lozenge
Probiotic S. salivarius K12 powderProbiotic S. salivarius K12 powderStreptococcus salivarius K12 powder
Probiotic S. salivarius M18 lozengesProbiotic S. salivarius M18 lozengesStreptococcus salivarius M18 lozenge
Probiotic S. salivarius K12 powder containing prebiotic AProbiotic S. salivarius K12 powder containing prebiotic AStreptococcus salivarius K12 powder with prebiotic
Probiotic S. salivarius K12 lozenges containing prebiotic AProbiotic S. salivarius K12 lozenges containing prebiotic AStreptococcus salivarius K12 lozenge with prebiotic
Probiotic S. salivarius K12 lozenges containing prebiotic A and BProbiotic S. salivarius K12 lozenges containing prebiotics A and BStreptococcus salivarius K12
Probiotic S. salivarius M18 lozenges der containing prebiotic BProbiotic S. salivarius M18 lozenges containing prebiotic BStreptococcus salivarius M18 lozenge with prebiotic
Probiotic S. salivarius M18 + lozenges containing prebiotic A and BProbiotic S. salivarius M18 + lozenges containing prebiotic A and BStreptococcus salivarius M18 lozenge with prebiotic
Probiotic S. salivarius M18 lozenges containing prebiotic AProbiotic S. salivarius M18 lozenges containing prebiotic AStreptococcus salivarius M18 lozenge with prebiotic
Primary Outcome Measures
NameTimeMethod
Change in microbial colonization from baseline (Day 0) to 24 hours or S. salivarius K12 lozenges24 hour

Study will determine the change in microbial colonization efficacy of Streptococcus salivarius K12 with or without prebiotics from a lozenge format. The statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to 24 hours after later across different formulations with the level of significance of p≤0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).

Change in microbial colonization from baseline (Day 0) to 1 hour for S. salivarius K12 lozenges1 hour

Study will determine the change in microbial colonization efficacy of Streptococcus salivarius K12 with or without prebiotics from a lozenge format. The statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to one hour after later across different formulations with the level of significance of p≤0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).

Change in microbial colonization from baseline (Day 0) to 48 hours or S. salivarius K12 lozenges48 hour

Study will determine the change in microbial colonization efficacy of Streptococcus salivarius K12 with or without prebiotics from a lozenge format. The statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to 48hours after later across different formulations with the level of significance of p≤0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).

in microbial colonization from baseline (Day 0) to 48 hours for S. salivarius K12 powder format48 hours

Study will determine the change in microbial colonization efficacy of Streptococcus salivarius K12 with or without prebiotics from a powder format. The statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to 48 hours after later across two different formulations with the level of significance of p≤0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).

Change in microbial colonization from baseline (Day 0) to 8 hours or S. salivarius K12 lozenges8 hour

Study will determine the change in microbial colonization efficacy of Streptococcus salivarius K12 with or without prebiotics from a lozenge format. The statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to eight hours after later across different formulations with the level of significance of p≤0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).

in microbial colonization from baseline (Day 0) to 8 hour for S. salivarius K12 powder format8 hours

Study will determine the change in microbial colonization efficacy of Streptococcus salivarius K12 with or without prebiotics from a powder format. The statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to 8 hours after later across two different formulations with the level of significance of p≤0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).

Change in microbial colonization from baseline (Day 0) to 1 hour for S. salivarius M18 lozenges1 hour

Study will determine the change in microbial colonization efficacy of Streptococcus salivarius M18 with or without prebiotics from a lozenge format. The statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to one hour after later across different formulations with the level of significance of p≤0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).

in microbial colonization from baseline (Day 0) to 24 hours for S. salivarius K12 powder format24 hours

Study will determine the change in microbial colonization efficacy of Streptococcus salivarius K12 with or without prebiotics from a powder format. The statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to 24 hours after later across two different formulations with the level of significance of p≤0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).

in microbial colonization from baseline (Day 0) to 1 hour for S. salivarius K12 powder format1 hour

Study will determine the change in microbial colonization efficacy of Streptococcus salivarius K12 with or without prebiotics from a powder format. The statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to one hour after later across two different formulations with the level of significance of p≤0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).

Change in microbial colonization from baseline (Day 0) to 8 hours for S. salivarius M18 lozenges8 hour

Study will determine the change in microbial colonization efficacy of Streptococcus salivarius M18 with or without prebiotics from a lozenge format. The statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to 8 hour after later across different formulations with the level of significance of p≤0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).

Change in microbial colonization from baseline (Day 0) to 24 hours for S. salivarius M18 lozenges24 hour

Study will determine the change in microbial colonization efficacy of Streptococcus salivarius M18 with or without prebiotics from a lozenge format. The statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to 24 hour after later across different formulations with the level of significance of p≤0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).

Change in microbial colonization from baseline (Day 0) to 48 hours for S. salivarius M18 lozenges48 hour

Study will determine the change in microbial colonization efficacy of Streptococcus salivarius M18 with or without prebiotics from a lozenge format. The statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to 48 hour after later across different formulations with the level of significance of p≤0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Blis Technologies Ltd

🇳🇿

Dunedin, Otago, New Zealand

© Copyright 2025. All Rights Reserved by MedPath